Integral Diagnostics Limited
ITGDF
$2.06
$0.687450.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 9.34% | 11.89% | 4.52% | 1.94% | 6.24% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.34% | 11.89% | 4.52% | 1.94% | 6.24% |
| Cost of Revenue | 11.44% | 14.05% | 4.31% | 1.74% | 6.68% |
| Gross Profit | 4.88% | 7.33% | 4.94% | 2.35% | 5.32% |
| SG&A Expenses | 6.64% | 9.13% | 6.24% | 3.62% | 4.16% |
| Depreciation & Amortization | 2.96% | 5.37% | 7.13% | 4.48% | 5.94% |
| Other Operating Expenses | -1.49% | 0.81% | -43.27% | -44.67% | -38.92% |
| Total Operating Expenses | 9.71% | 12.28% | 4.58% | 2.00% | 5.85% |
| Operating Income | 5.19% | 7.65% | 3.94% | 1.38% | 10.64% |
| Income Before Tax | 100.59% | 100.60% | -29.91% | -31.64% | -452.60% |
| Income Tax Expenses | -21.04% | -19.18% | -21.77% | -23.70% | -58.22% |
| Earnings from Continuing Operations | 99.41% | 99.39% | -32.89% | -34.54% | -509.93% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 99.41% | 99.39% | -32.89% | -34.54% | -509.93% |
| EBIT | 5.19% | 7.65% | 3.94% | 1.38% | 10.64% |
| EBITDA | 4.00% | 6.43% | 3.95% | 1.39% | 8.82% |
| EPS Basic | 99.46% | 99.47% | -33.59% | -35.11% | -509.21% |
| Normalized Basic EPS | -94.00% | -94.00% | 706.25% | 706.25% | -69.33% |
| EPS Diluted | 99.46% | 99.47% | -41.60% | -42.97% | -514.67% |
| Normalized Diluted EPS | -94.00% | -94.00% | 740.00% | 687.50% | -68.94% |
| Average Basic Shares Outstanding | 6.11% | 6.11% | 0.36% | 0.36% | 0.31% |
| Average Diluted Shares Outstanding | 6.11% | 6.11% | 1.44% | 1.44% | -0.99% |
| Dividend Per Share | 0.00% | 2.44% | -6.84% | -9.17% | -1.22% |
| Payout Ratio | -167.69% | -167.69% | 0.53% | 0.53% | -1.28% |